Mercè Borràs

ORCID: 0000-0002-7498-4773
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dialysis and Renal Disease Management
  • Blood Pressure and Hypertension Studies
  • Cardiovascular Health and Disease Prevention
  • Parathyroid Disorders and Treatments
  • Central Venous Catheters and Hemodialysis
  • Cerebrovascular and Carotid Artery Diseases
  • Peripheral Artery Disease Management
  • Pharmacological Effects and Toxicity Studies
  • Vitamin D Research Studies
  • Healthcare cost, quality, practices
  • Health Systems, Economic Evaluations, Quality of Life
  • Magnesium in Health and Disease
  • Neurological and metabolic disorders
  • Renal Diseases and Glomerulopathies
  • Muscle and Compartmental Disorders
  • Potassium and Related Disorders
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Genetic and Kidney Cyst Diseases
  • Nephrotoxicity and Medicinal Plants
  • Congenital Anomalies and Fetal Surgery
  • Medical Imaging and Pathology Studies
  • Renal function and acid-base balance
  • Drug-Induced Hepatotoxicity and Protection
  • Intestinal and Peritoneal Adhesions
  • Protease and Inhibitor Mechanisms

Universitat de Lleida
1993-2025

Hospital Universitari Arnau de Vilanova
2009-2025

Hospital Universitari Joan XXIII de Tarragona
2022

Biomedical Research Institute of Lleida
2010-2018

Instituto de Salud Carlos III
2017-2018

Hospital Arnau de Vilanova
1993-2009

Hospital de Galdakao
1999

Deleted Institution
1999

Pediatric Nephrology of Alabama
1996

Hospital Universitari Germans Trias i Pujol
1993

Background. Dialysis Outcomes and Practice Patterns Study has shown that the proportion of haemodialysis patients with adequate mineral metabolism parameters according to Kidney Disease Outcome Quality Initiative (K/DOQI) guidelines is very low. The adequacy such in relation recommended ranges different chronic kidney disease (CKD) stages not been reported. objective this study provide an in-depth description early CKD a European population, compare it current recommendations for 3–5 (K/DOQI...

10.1093/ndt/gfl718 article EN Nephrology Dialysis Transplantation 2007-01-06

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with chronic kidney (CKD). risk assessment this population hampered by failure traditional factors to fully account for elevated CVD (reverse epidemiology effect) presence emerging specifically related failure. Therefore, diagnostic tools capable improving cardiovascular beyond are currently warranted. We present protocol a 4-year prospective study aimed assess predictive value non-invasive imaging...

10.1186/1471-2369-11-14 article EN cc-by BMC Nephrology 2010-07-07

Summary Background and objectives Vascular calcification (VC) has a significant effect in cardiovascular diseases on dialysis patients. However, VC is assessed with x-ray-based techniques, which do not inform about calcium localization (intima, media, atherosclerosis-related). The aim of this work to study its related factors using arterial ultrasound report the exact location calcium. Design, setting, participants, & measurements This was an observational, cross-sectional, case-control...

10.2215/cjn.04290510 article EN Clinical Journal of the American Society of Nephrology 2010-10-08

Previous studies highlighted the utility of individual urinary biomarkers in prediction interstitial fibrosis IgA Nephropathy patients. However, it´s uncertain which biomarker or combination provides a more accurate estimation renal Surface. Herein, we measured excretion set seven tubular injury group patients with primary and analyzed their as non-invasive estimators area found on kidney biopsy. Two hundred forty-seven adults diagnosed by biopsy control 50 healthy were included. The EGF,...

10.1186/s12882-025-04049-8 article EN cc-by-nc-nd BMC Nephrology 2025-03-20

The long-term clinical effects of the use a low calcium concentration in dialysate are largely unknown. For this reason, influence low-calcium on parathyroid hormone (PTH) secretion hemodialysis patients and its effect severity secondary hyperparathyroidism were studied. In 35 patients, was lowered from 1.75 to 1.25 mmol/L. Twelve months later, serum iPTH levels increased significantly 18.6 33.2 pmol/L so did alkaline phosphatase levels, 210 330 IU/L, without significant changes or...

10.1681/asn.v61132 article EN Journal of the American Society of Nephrology 1995-07-01

Background. Cardiovascular risk scoring (Score) does not specifically address chronic kidney disease (CKD) patients. The aim of our study is to quantify atherosclerosis using carotid ultrasound and ankle–brachial index (ABI) assess its additional value in scoring. Methods. In this cross-sectional, observational study, patients were studied according a standardized protocol including ABI determine the score (AS), ranging from absence severe (AS 0 AS 3). Results. We included 409 CKD-affected...

10.1093/ndt/gfq109 article EN Nephrology Dialysis Transplantation 2010-03-17

Las infecciones peritoneales siguen constituyendo una complicación muy relevante de la diálisis peritoneal, por su incidencia todavía elevada y sus importantes consecuencias clínicas, en términos mortalidad, fracaso técnica costes para el sistema sanitario. prácticas prevención tratamiento esta muestran notable heterogeneidad derivada, entre otros factores, complejidad del problema escasez evidencia clínica que permitan responder manera clara a muchas las dudas planteadas. El propósito este...

10.1016/j.nefro.2021.10.007 article ES cc-by-nc-nd Nefrología 2022-01-04

The early identification of the onset subclinical atheromatosis is essential in reducing high mortality risk from cardiovascular disease (CVD) worldwide. Although carotid intima-media thickness (cIMT) most commonly used predictor ongoing atherosclerosis, an experimental model demonstrated that increases adventitial microvessels (vasa vasorum (VV)) precede endothelial dysfunction. Using reported accuracy contrast-enhanced ultrasound (CEU) to measure VV, this study assessed whether...

10.1186/s12947-015-0014-7 article EN cc-by Cardiovascular Ultrasound 2015-04-15

Acquired cystic kidney disease (ACKD) can bedeveloped during chronic renal insufficiency. Theprobability of developing diseases rises with theincrease time in dialysis [1]. Men and African-AmericanpopulationaremorelikelytodevelopACKD.Also, volumes are bigger cyst size increasesfaster this population [1,2]. Typical complicationsof ACKD intra- pericystic bleeding as wellas rupture retroperitoneal haemorrhage. Patientswith also present a higher risk malignanttransformation. Haemoperitoneum is an...

10.1093/ndt/gfi298 article EN Nephrology Dialysis Transplantation 2005-12-20

<b><i>Background:</i></b> There is controversy concerning the compared rates of decline residual kidney function (RKF) in patients treated with continuous ambulatory peritoneal dialysis (CAPD) and automated (APD). <b><i>Objectives Method:</i></b> Following an observational, multicenter design, we studied 493 initiating (PD) four different Spanish units. We explored effect PD modality on rate RKF probability anuria during follow-up. applied...

10.1159/000368933 article EN Nephron Clinical Practice 2015-01-08

Background Baseline residual kidney function (RKF) and its rate of decline during follow-up are purported to be reliable outcome predictors patients undergoing Peritoneal Dialysis (PD). The independent contribution each these factors has not been elucidated. Method We report a multicenter, longitudinal study 493 incident on PD satisfying two conditions: glomerular filtration (GFR) ≥1 mL/minute daily diuresis ≥300 mL. main variables were the GFR (mean urea creatinine clearances) at inception...

10.1371/journal.pone.0158696 article EN cc-by PLoS ONE 2016-07-08

<b><i>Background:</i></b> The prevalence of subclinical atherosclerosis and the main predictors progression this condition in patients undergoing peritoneal dialysis (PD) have been insufficiently investigated. <b><i>Objectives Method:</i></b> Following a prospective, multicenter, observational design, we studied 237 who were treated with PD for ≥3 months, without any clinical background cardiovascular (CV) disease. Our objectives following: (1)...

10.1159/000458418 article EN ˜The œNephron journals/Nephron journals 2017-01-01

Initiation of peritoneal dialysis (PD) with 3 exchanges has become common practice in recent years, despite the lack published clinical data.To describe experience incremental (IPD) at a single site.A total 46 IPD patients undergoing 2-year clinical, laboratory, treatment and progression follow-up.To 25% were trasplanted on IPD. Mean time before transfer to conventional PD 24 months, half because fluid balance. Good biochemical results peritonitis rate one episode per 99 months. There was an...

10.1016/j.nefro.2016.01.006 article EN cc-by-nc-nd Nefrología 2016-05-01

Sevelamer hydrochloride is a phosphate binder widely employed in hemodialysis patients. Until now, information about its efficacy and safety peritoneal dialysis patients has been scarce.In September 2005 cross-sectional study of demographic, biochemical, therapeutic data from 10 units Catalonia the Balearic Islands, Spain, was conducted.We analyzed 228 At time study, 128 (56%) were receiving sevelamer. Patients sevelamer younger (p < 0.01), showed longer period on had lower Charlson...

10.1177/089686080702700618 article EN Peritoneal Dialysis International 2007-11-01

Initiation of peritoneal dialysis (PD) with 3 exchanges has become common practice in recent years, despite the lack published clinical data. To describe experience incremental (IPD) at a single site. A total 46 IPD patients undergoing 2-year clinical, laboratory, treatment and progression follow-up. 25% were transplanted on IPD. Mean time before transfer to conventional PD 24 months, half because fluid balance. Good biochemical results peritonitis rate one episode per 99 months. There was...

10.1016/j.nefroe.2016.06.011 article ES cc-by-nc-nd Nefrología (English Edition) 2016-05-01
Coming Soon ...